GoodRx built the most trusted prescription savings brand in America. The next chapter is bigger: becoming the payment and settlement layer for healthcare — eliminating fee leakage, owning the transaction, and building the loyalty infrastructure that makes patients come back.
GoodRx has become the most trusted brand in prescription savings. But trust alone isn't infrastructure. Every time a patient fills a prescription, money settles somewhere. Today, GoodRx is adjacent to that settlement. GoodRx Pay puts GoodRx inside it.
Becoming the payment layer means four things: owning the preferred payment method on GoodRx.com, eliminating the 3–4% Stripe fees GoodRx pays on every transaction today, settling $3.5B in manufacturer rebates in real time instead of delayed batches — capturing float and new economics — and extending closed-loop rails to preferred pharmacies like Walgreens, splitting the interchange savings as a new revenue stream. The Lynx-powered Subsidy Wallet launching 7/1/26 is the first proof point — and the chassis for all of it.
Three phases. One chassis. Each milestone expands the same Lynx-powered wallet into a wider set of constituents and use cases.
Lynx is the payment engine underneath GoodRx Pay — handling drug-level eligibility, multi-purse routing, and real-time settlement before the pharmacist hands over the bag.
Most payment platforms restrict to a merchant category. Lynx enforces eligibility at the 11-digit NDC code — exact drug, dose form, and strength. A GLP-1 subsidy approves Ozempic 1mg NDC 00169-4130-11 and blocks everything else in the same transaction. No generic payments infrastructure does this.
Today, manufacturer rebates settle as anonymous ACH batches — weeks after the transaction, invisible to the patient, a liability sitting on the pharmacy's balance sheet, opaque data for the manufacturer. GoodRx Pay transforms the rebate into a named wallet account tied to the individual: the transaction, the drug, the patient, and the rebate all live inside one cohesive GoodRx-controlled record.
Once GoodRx owns the payment rail — for subsidies, rebates, employer benefits, and consumer-directed funds — it has everything needed to build the most powerful loyalty program in retail healthcare. Target and Starbucks showed how. GoodRx can do both, at a scale neither reached in healthcare, and extend it to every partner pharmacy and supermarket in the network.
That's the addressable opportunity when GoodRx extends its closed-loop payment rails to its preferred pharmacy network. The same infrastructure built for the GLP-1 wallet. The same Lynx rails. New relationships, new revenue — and a structural reason for every major pharmacy chain to make GoodRx Pay their preferred payment partner.
Six steps. One GoodRx experience. Under one second.
Not a card. Not a coupon. Not a fragmented benefit. One elegant wallet where every pool of value lives together — and sequences automatically at the point of care.
GoodRx Pay is the path from discovery utility to critical payment infrastructure — owning the moment dollars settle in healthcare, eliminating fees, settling rebates in real time, and earning a share of the $10B+ in interchange GoodRx pharmacy partners pay every year.
See the full economic model →